Despite Downturn, Investment Firm Survey Sees Emerging Uses for Microarrays | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Despite recent concerns about declining interest in and uses for microarray technology, the results of a survey conducted by investment firm William Blair suggest the technology still has a place in the research world, though likely in certain emerging applications.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: role for RNA splicing in genetic variation, and more.

An advocacy group sues the US Food and Drug Administration over redactions of information about advisory committee members, Stat News reports.

Mexico is trying to lure young genomics researchers back home with their own labs, Science reports.

A molecular autopsy has aided a woman's search for why sudden cardiac death has stalked her family, the Wall Street Journal reports.